Irish EUR

Uniphar plc (UPR.IR)

Compare
1.9320
-0.0180
(-0.92%)
At close: January 10 at 4:30:23 PM GMT
Loading Chart for UPR.IR
DELL
  • Previous Close 1.9500
  • Open 1.9280
  • Bid 1.9100 x --
  • Ask 1.9360 x --
  • Day's Range 1.9040 - 1.9520
  • 52 Week Range 1.9040 - 3.0000
  • Volume 151,504
  • Avg. Volume 318,935
  • Market Cap (intraday) 532.38M
  • Beta (5Y Monthly) 0.79
  • PE Ratio (TTM) 12.08
  • EPS (TTM) 0.1600
  • Earnings Date Feb 25, 2025 - Mar 3, 2025
  • Forward Dividend & Yield 0.02 (0.96%)
  • Ex-Dividend Date Sep 12, 2024
  • 1y Target Est 4.55

Uniphar plc operates as a diversified healthcare services company in the Republic of Ireland, the United Kingdom, The Netherlands, and internationally. The company operates through three divisions: Medtech, Pharma, and Supply Chain & Retail. The Medtech division offers outsourced sales; and marketing, distribution, and support services to medical device manufacturers. The Pharma division provides high value services across the lifecycle of a pharmaceutical product; and healthcare professionals with access to medicines it cannot source through traditional channels, as well as operates its on demand and pharma service units. The Supply Chain & Retail division engages in pre-wholesale and wholesale distribution of pharmaceutical, healthcare, and animal health products to pharmacies, hospitals, and veterinary surgeons; and operates a network of pharmacies under the Life, Allcare, and Hickey's brands. It also offers pharmacy support, pharmaceutical supply chain, specialist nursing and infusion, medical device distribution, healthcare technology, outsourcing and resourcing, telecommunications support, pharmaceutical advisory, medical affairs, and online pharmacy and product fostering services, as well as specialist provider of pharmaceuticals. Uniphar plc was founded in 1967 and is headquartered in Dublin, Ireland.

www.uniphar.ie

3,000

Full Time Employees

December 31

Fiscal Year Ends

Recent News: UPR.IR

View More

Performance Overview: UPR.IR

Trailing total returns as of 1/10/2025, which may include dividends or other distributions. Benchmark is

.

YTD Return

UPR.IR
8.87%
ISEQ All Share
1.05%

1-Year Return

UPR.IR
23.99%
ISEQ All Share
11.39%

3-Year Return

UPR.IR
57.69%
ISEQ All Share
11.87%

5-Year Return

UPR.IR
57.97%
ISEQ All Share
32.64%

Compare To: UPR.IR

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: UPR.IR

View More

Valuation Measures

Annual
As of 1/10/2025
  • Market Cap

    527.47M

  • Enterprise Value

    849.70M

  • Trailing P/E

    11.71

  • Forward P/E

    8.78

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.20

  • Price/Book (mrq)

    1.51

  • Enterprise Value/Revenue

    0.32

  • Enterprise Value/EBITDA

    7.40

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    1.69%

  • Return on Assets (ttm)

    3.76%

  • Return on Equity (ttm)

    13.91%

  • Revenue (ttm)

    2.68B

  • Net Income Avi to Common (ttm)

    45.17M

  • Diluted EPS (ttm)

    0.1600

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    96M

  • Total Debt/Equity (mrq)

    119.43%

  • Levered Free Cash Flow (ttm)

    111.39M

Research Analysis: UPR.IR

View More

Company Insights: UPR.IR

Research Reports: UPR.IR

View More

People Also Watch